PPIs Linked to Worse Outcomes With Widely Used Breast Cancer Drug
Using proton pump inhibitors (PPIs) during treatment with palbociclib (Ibrance) was linked to higher risks of progression and death among patients with breast cancer, according
Using proton pump inhibitors (PPIs) during treatment with palbociclib (Ibrance) was linked to higher risks of progression and death among patients with breast cancer, according
Over the last 40 years, twin packs of EpiPens became a fixture for people and parents with children experiencing severe allergic reactions. Now, ARS Pharmaceuticals
A history of sinus congestion and drip may be a precursor to serious autoimmune disorders, a population-based study suggested. Rates of rheumatologic conditions including antiphospholipid